| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Liang-Rong Zheng | Q89521215 |
| Jian Yang | Q89521218 | ||
| P2093 | author name string | Chi Zhang | |
| Fen Zhang | |||
| Xi-Ying Wang | |||
| P2860 | cites work | Circulating microRNAs are new and sensitive biomarkers of myocardial infarction | Q24606701 |
| Human cardiac troponin complex. Structure and functions | Q26825137 | ||
| Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis | Q27012693 | ||
| Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure | Q27027081 | ||
| Natriuretic peptide tests in suspected acute heart failure | Q48297053 | ||
| Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia. | Q48610344 | ||
| The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes | Q48766104 | ||
| The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes | Q48960064 | ||
| Galectin-3 in patients with coronary heart disease and atrial fibrillation | Q49487436 | ||
| Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides | Q49888500 | ||
| Platelet microRNA for predicting acute myocardial infarction | Q50067467 | ||
| Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin | Q50217429 | ||
| Short-term Changes in Gal 3 Circulating Levels After Acute Myocardial Infarction. | Q50860814 | ||
| Heart-type fatty acid binding protein is a sensitive biomarker for early AMI detection in troponin negative patients: a pilot study. | Q50923360 | ||
| Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T - Sub-analysis from the TRAPID-AMI study. | Q50930891 | ||
| Comparison of prognostic significance of mean platelet volume/platelet count with GRACE for long-term prognosis in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. | Q51057442 | ||
| IL-37 increased in patients with acute coronary syndrome and associated with a worse clinical outcome after ST-segment elevation acute myocardial infarction. | Q51122598 | ||
| Age and Gender Tailored Cutoff Value of hs-cTnT Contributes to Rapidly Diagnose Acute Myocardial Infarction in Chest Pain Patients. | Q51151304 | ||
| Pregnancy-associated plasma protein-A (PAPP-A) as a possible biomarker in patients with coronary artery disease. | Q51405047 | ||
| Diurnal Rhythm of Cardiac Troponin: Consequences for the Diagnosis of Acute Myocardial Infarction. | Q51426952 | ||
| Growth differentiation factor-15 predicts the prognoses of patients with acute coronary syndrome: a meta-analysis | Q28066559 | ||
| The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting | Q28084405 | ||
| Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy | Q28304526 | ||
| Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor | Q28579840 | ||
| Circulating soluble CD40 ligand mediates the interaction between neutrophils and platelets in acute coronary syndrome | Q33646945 | ||
| Clinical and genetic correlates of growth differentiation factor 15 in the community | Q34114806 | ||
| The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department | Q34134378 | ||
| Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage | Q34189929 | ||
| Current concepts of the pathogenesis of the acute coronary syndromes | Q34310339 | ||
| Long noncoding RNAs in patients with acute myocardial infarction | Q34429560 | ||
| Atrial natriuretic peptides in plasma. | Q34435237 | ||
| 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati | Q34491521 | ||
| 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut | Q34527664 | ||
| 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society o | Q34556019 | ||
| Emerging biomarkers in heart failure and cardiac cachexia | Q34836097 | ||
| Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study | Q35021094 | ||
| High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy | Q35648924 | ||
| Natriuretic peptide metabolism, clearance and degradation | Q35831469 | ||
| Reduced SIRT1 expression correlates with enhanced oxidative stress in compensated and decompensated heart failure | Q35947151 | ||
| Heart Fatty Acid Binding Protein and cardiac troponin: development of an optimal rule-out strategy for acute myocardial infarction | Q36117869 | ||
| C-reactive protein increase in unstable coronary disease cause or effect? | Q36286821 | ||
| Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain | Q36426643 | ||
| High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study | Q36613661 | ||
| Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure | Q36757833 | ||
| Pregnancy-associated plasma protein A predicts adverse vascular events in patients with coronary heart disease: a systematic review and meta-analysis | Q36984041 | ||
| Understanding amino-terminal pro-B-type natriuretic peptide in obesity | Q37075421 | ||
| Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease | Q37076194 | ||
| Pre-operative risk assessment and risk reduction before surgery | Q37164914 | ||
| State of the art: using natriuretic peptide levels in clinical practice | Q37257460 | ||
| Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores | Q37441199 | ||
| Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials | Q37584696 | ||
| Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis. | Q37599608 | ||
| Cardiac troponin may be released by ischemia alone, without necrosis | Q37662944 | ||
| Fourth Universal Definition of Myocardial Infarction (2018) | Q91182292 | ||
| Growth differentiation factor-15 and the risk of cardiovascular diseases and all-cause mortality: A meta-analysis of prospective studies | Q91274465 | ||
| The role of microRNAs in congenital heart disease | Q91531450 | ||
| Performance of Copeptin for Early Diagnosis of Acute Myocardial Infarction in an Emergency Department Setting | Q92741233 | ||
| [Combined high-sensitivity copeptin and troponin T evaluation for the diagnosis of non-ST elevation acute coronary syndrome in the emergency department] | Q95383244 | ||
| Cardiovascular disease in Europe 2015: epidemiological update | Q95784620 | ||
| Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial | Q47100046 | ||
| Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial | Q47106217 | ||
| Circulating Long Noncoding RNA HOTAIR is an Essential Mediator of Acute Myocardial Infarction | Q47275060 | ||
| Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction. | Q47275584 | ||
| Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score | Q47597427 | ||
| External validation of heart-type fatty acid binding protein, high-sensitivity cardiac troponin, and electrocardiography as rule-out for acute myocardial infarction | Q47622781 | ||
| Left atrial volume index in patients with heart failure and severely impaired left ventricular systolic function: the role of established echocardiographic parameters, circulating cystatin C and galectin-3. | Q47920631 | ||
| Prognostic Value of Serial Galectin-3 Measurements in Patients With Acute Heart Failure | Q47944097 | ||
| Relationship Between C-Reactive Protein Serum Concentration and the 1846 C>T (rs1205) Polymorphism in Patients with Acute Coronary Syndrome from Western Mexico | Q47962222 | ||
| Multibiomarker analysis in patients with acute myocardial infarction | Q48165741 | ||
| The renal and cardiovascular effects of natriuretic peptides | Q48230309 | ||
| Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin | Q37670587 | ||
| Elevated plasma interleukin-37 playing an important role in acute coronary syndrome through suppression of ROCK activation | Q37706045 | ||
| Expression and function of microRNAs in heart disease | Q37736516 | ||
| Can YKL-40 be a new inflammatory biomarker in cardiovascular disease? | Q37878029 | ||
| Cardiac troponins I and T: molecular markers for early diagnosis, prognosis, and accurate triaging of patients with acute myocardial infarction | Q38062864 | ||
| Copeptin and cardiovascular disease: a review of a novel neurohormone | Q38072505 | ||
| Biomarkers and diagnostics in heart failure | Q38073516 | ||
| Cystatin C: an emerging biomarker in cardiovascular disease | Q38087416 | ||
| Natriuretic peptides in cardiovascular diseases: current use and perspectives | Q38162429 | ||
| Biomarkers and acute coronary syndromes: an update | Q38172885 | ||
| Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study). | Q38179689 | ||
| The role of cardiac biomarkers in cardiovascular disease risk assessment | Q38213478 | ||
| Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure | Q38261513 | ||
| Beyond cardiac troponin: recent advances in the development of alternative biomarkers for cardiovascular disease | Q38353580 | ||
| Diagnostics on acute myocardial infarction: Cardiac troponin biomarkers. | Q38404949 | ||
| Analytical validation of novel cardiac biomarkers used in clinical trials | Q38475286 | ||
| SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection | Q38665115 | ||
| Application of Cardiac Troponin in Cardiovascular Diseases Other Than Acute Coronary Syndrome | Q39034907 | ||
| Medium platelet volume as a noninvasive predictor of chronic total occlusion in non-infarct artery in patients with non-ST-segment elevation myocardial infarction and multivessel coronary artery disease | Q39152506 | ||
| Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure | Q39223911 | ||
| Stratification of ST-elevation myocardial infarction patients based on soluble CD40L longitudinal changes. | Q39771755 | ||
| Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease | Q39903699 | ||
| Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction. | Q39938287 | ||
| Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial | Q40132501 | ||
| Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure | Q40421487 | ||
| Changes of soluble CD40 ligand in the progression of acute myocardial infarction associate to endothelial nitric oxide synthase polymorphisms and vascular endothelial growth factor but not to platelet CD62P expression. | Q40637312 | ||
| Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational study. | Q40873832 | ||
| Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study | Q41037978 | ||
| Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure | Q41060281 | ||
| TREM-1 Mediates Inflammatory Injury and Cardiac Remodeling Following Myocardial Infarction | Q41117385 | ||
| Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study | Q41140893 | ||
| Biomarker-assist score for reverse remodeling prediction in heart failure: The ST2-R2 score. | Q41311637 | ||
| Copeptin (C-terminal pro arginine-vasopressin) is an independent long-term prognostic marker in heart failure with reduced ejection fraction | Q41531281 | ||
| Performances of the heart fatty acid protein assay for the rapid diagnosis of acute myocardial infarction in ED patients | Q41641074 | ||
| Prognostic evaluation of soluble CD40L in acute myocardial infarction: is not fancy, is science! | Q42181380 | ||
| Identification of long non-coding RNAs biomarkers for early diagnosis of myocardial infarction from the dysregulated coding-non-coding co-expression network | Q42317549 | ||
| Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only | Q43017128 | ||
| Predictive value of elevated cystatin C in patients undergoing primary angioplasty for ST-elevation myocardial infarction | Q43805298 | ||
| Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. | Q43839080 | ||
| Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3. | Q44118879 | ||
| Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin | Q44747382 | ||
| Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes | Q45743912 | ||
| The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis | Q46156825 | ||
| Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction | Q46601750 | ||
| Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention | Q47095088 | ||
| Eplerenone Modulates Interleukin-33/sST2 Signaling and IL-1β in Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction. | Q51736629 | ||
| Novel genes detected by transcriptional profiling from whole-blood cells in patients with early onset of acute coronary syndrome. | Q51821862 | ||
| Release kinetics of inflammatory biomarkers in a clinical model of acute myocardial infarction. | Q52991956 | ||
| Association of serum cystatin C levels with myocardial perfusion and cardiac functional recovery in patients with anterior wall ST elevation myocardial infarction treated with primary coronary intervention. | Q53306249 | ||
| [Diagnostic value of combining serum soluble ST2 and interleukin-33 for heart failure patients with preserved left ventricular ejection fraction]. | Q54401412 | ||
| Prognostic implications of high-sensitivity cardiac troponin T assay in a real-world population with non-ST-elevation acute coronary syndrome☆. | Q55278810 | ||
| The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide | Q56882285 | ||
| Prognostic role of soluble ST2 in acute coronary syndrome with diabetes | Q57163517 | ||
| Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome | Q58121766 | ||
| How to use high-sensitivity cardiac troponins in acute cardiac care | Q58314226 | ||
| Recommendations for the use of cardiac troponin measurement in acute cardiac care | Q58314269 | ||
| Cystatin C for predicting all-cause mortality and rehospitalization in patients with heart failure: a meta-analysis | Q61799192 | ||
| Low expression of PRMT5 in peripheral blood may serve as a potential independent risk factor in assessments of the risk of stable CAD and AMI | Q61804733 | ||
| Cardiac myosin-binding protein C: how a novel biomarker could transform chest pain triage | Q62010915 | ||
| Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction | Q62128738 | ||
| Circadian rhythm of cardiac troponin I and its clinical impact on the diagnostic accuracy for acute myocardial infarction | Q62128743 | ||
| Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction | Q62128944 | ||
| Sex-Specific Versus Overall Clinical Decision Limits for Cardiac Troponin I and T for the Diagnosis of Acute Myocardial Infarction: A Systematic Review | Q63871528 | ||
| TREML4 mRNA Expression and Polymorphisms in Blood Leukocytes are Associated with Atherosclerotic Lesion Extension in Coronary Artery Disease | Q64059223 | ||
| Low expression of PIK3C2A gene: A potential biomarker to predict the risk of acute myocardial infarction | Q64227532 | ||
| Cardiac Myosin-Binding Protein C-From Bench to Improved Diagnosis of Acute Myocardial Infarction | Q64245221 | ||
| Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention. | Q64945080 | ||
| Clinical role of serum Copeptin in acute coronary syndrome. | Q64986825 | ||
| Circulating Pregnancy-Associated Plasma Protein A Predicts Outcome in Patients With Acute Coronary Syndrome but No Troponin I Elevation | Q79125164 | ||
| National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes | Q80033635 | ||
| Natriuretic peptides | Q80396416 | ||
| Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes | Q80627335 | ||
| Use of circulating microRNAs to diagnose acute myocardial infarction | Q83262798 | ||
| Plasma microRNA 499 as a biomarker of acute myocardial infarction | Q84068842 | ||
| Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling | Q84916626 | ||
| Association between the SIRT1 mRNA expression and acute coronary syndrome | Q85849381 | ||
| The prognostic value of admission mean platelet volume to platelet count ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention | Q86129756 | ||
| Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction | Q86135613 | ||
| Prognostic implications of low level cardiac troponin elevation using high-sensitivity cardiac troponin T | Q86864086 | ||
| Relationship of Endothelial Cell-Specific Molecule 1 Level in Stress Hyperglycemia Patients With Acute ST-Segment Elevation Myocardial Infarction: A Pilot Study | Q86941086 | ||
| Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction | Q87367180 | ||
| Prognostic value of soluble ST2 in the Valsartan Heart Failure Trial | Q87429239 | ||
| Diagnostic role of copeptin in patients presenting with chest pain in the emergency room | Q87439041 | ||
| High-sensitivity cardiac troponin T is superior to troponin I in the prediction of mortality in patients without acute coronary syndrome | Q87869077 | ||
| Modulation of IL-33/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers | Q87895868 | ||
| Predictive Value of Mean Platelet Volume/Platelet Count for Prognosis in Acute Myocardial Infarction | Q88124681 | ||
| Increased Cystatin C Level in ST-Elevation Myocardial Infarction Predisposes the Prognosis of Angioplasty | Q89066970 | ||
| Admission Endocan Level may be a Useful Predictor for In-Hospital Mortality and Coronary Severity Index in Patients With ST-Segment Elevation Myocardial Infarction | Q89198566 | ||
| Serum Endothelial Cell-Specific Molecule 1 (Endocan) Levels in Patients With Acute Myocardial Infarction and Its Clinical Significance | Q89287462 | ||
| Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial | Q89400922 | ||
| The utility of inflammation and platelet biomarkers in patients with acute coronary syndromes | Q90039555 | ||
| Comparison of the Effects of Ticagrelor and Clopidogrel on Inflammatory Factors, Vascular Endothelium Functions and Short-Term Prognosis in Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Emergency Percutaneous Coronary Int | Q90284436 | ||
| Circulating Long Noncoding RNA LIPCAR Acts as a Novel Biomarker in Patients with ST-Segment Elevation Myocardial Infarction | Q90379386 | ||
| Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction - A multicenter study | Q91024200 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | heart failure | Q181754 |
| acute myocardial infarction | Q18558122 | ||
| biomarker | Q864574 | ||
| P304 | page(s) | 2018035 | |
| P577 | publication date | 2020-01-17 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | The Biomarkers for Acute Myocardial Infarction and Heart Failure | |
| P478 | volume | 2020 |
Search more.